Cutler Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cutler Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$8K	–	3279
2023 Q4	$8K	Buy	+100	New	+$7.84K	﹤0.01%	2533
2023 Q1	–	Sell	-3	Closed	-$231	–	4502
2022 Q4	$0	Buy	+3	New	+$221	﹤0.01%	5022
2022 Q2	–	Sell	-100	Closed	-$7.81K	–	5503
2022 Q1	$7K	Buy	+100	New	+$7.65K	﹤0.01%	3904
2020 Q3	–	Sell	-500	Closed	-$31K	–	5132
2020 Q2	$31K	Sell	500 -1,000	-67%	-$60.5K	﹤0.01%	2081
2020 Q1	$81K	Buy	+1,500	New	+$92.4K	﹤0.01%	1452
2016 Q4	–	Sell	-673	Closed	-$38K	–	7143
2016 Q3	$38K	Hold	673	–	–	﹤0.01%	2730
2016 Q2	$39K	Sell	673 -1,777	-73%	-$104K	﹤0.01%	2615
2016 Q1	$140K	Buy	+2,450	New	+$145K	0.01%	1297

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cutler Group's PPH Position: Q1 2024 in Review

Cutler Group sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2024, closing a stake of 100 shares — an estimated $8K sold.

Cutler Group first reported a position in PPH in Q1 2016 and held it in 8 quarters. The position peaked at $140K in Q1 2016. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

Cutler Group reported no remaining VanEck Pharmaceutical ETF position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 100 VanEck Pharmaceutical ETF shares in Q1 2024, an estimated $8K.
Cutler Group first reported a position in VanEck Pharmaceutical ETF in Q1 2016 and held it in 8 quarters.
Cutler Group's VanEck Pharmaceutical ETF position peaked at $140K in Q1 2016.
138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.